Looking for a Zepbound Alternative?
Quick answer
Zepbound is Eli Lilly's brand-name tirzepatide approved specifically for weight management. It costs approximately $1,059/mo without insurance. LYV prescribes compounded tirzepatide -- the same active molecule -- from $197/mo. Both provide the dual GIP/GLP-1 mechanism that produced 22.5% body weight loss in the SURMOUNT trials.
What Zepbound offers
Zepbound launched in late 2023 as the first tirzepatide product specifically approved for chronic weight management. The clinical data behind it is exceptional -- the SURMOUNT trial series produced the largest weight losses ever seen in obesity pharmacotherapy. Eli Lilly's delivery device is a well-engineered auto-injector pen, and the dosing protocol is clearly established. Zepbound rightfully earned its FDA approval, and for patients with insurance coverage, it is an effective and convenient option.
Zepbound vs LYV
| Zepbound | LYV | |
|---|---|---|
| Active compound | Tirzepatide | Tirzepatide |
| FDA indication | Chronic weight management | Compounded (same molecule, no individual product approval) |
| Monthly cost | ~$1,059/mo retail | From $197/mo |
| Manufacturer | Eli Lilly | Licensed US compounding pharmacy |
| Delivery | Pre-filled auto-injector pen | Pre-dosed pens, shipped monthly |
| Insurance | Covered by some plans | Cash-pay, transparent pricing |
| Dose customization | 6 fixed increments | Custom dosing per provider |
| Additional compounds | Tirzepatide only | Also NAD+, sermorelin, glutathione, ED, hair |
Where LYV differs
- •The core compound is the same. LYV's advantage is accessibility -- $197/mo vs $1,059/mo puts tirzepatide within reach for patients who cannot afford brand-name or do not have insurance coverage.
- •LYV's all-inclusive pricing covers provider consultation, prescription, and shipping. Zepbound requires a separate doctor visit, separate pharmacy interaction, and potentially separate insurance pre-authorization.
- •Custom dosing through compounding means your provider can fine-tune beyond Eli Lilly's six fixed options. This can help during titration when a dose between increments would be ideal.
- •LYV is more than weight loss. If you also want NAD+ for energy, sermorelin for recovery, or ED treatment, one provider manages everything together.
Frequently asked questions
Is compounded tirzepatide the same as Zepbound?
Same active molecule, different source. Zepbound is manufactured by Eli Lilly. Compounded tirzepatide is prepared by licensed US pharmacies. The tirzepatide compound is identical. Clinical mechanism, appetite reduction, and expected weight loss are the same at equivalent doses.
Why would I choose compounded over Zepbound?
Cost. At $197/mo vs $1,059/mo, the savings are over $10,000 per year. If your insurance does not cover Zepbound (many plans still do not cover weight management medications), compounded tirzepatide through LYV delivers the same compound at a price that is sustainable long-term.
Is Zepbound better because it is FDA-approved?
Zepbound's FDA approval means the specific manufactured product went through the full approval process. The active molecule -- tirzepatide -- is the same. Compounding pharmacies are FDA-regulated and prepare the same compound. The clinical evidence for tirzepatide applies to the molecule, not the brand name.
What if Zepbound becomes cheaper?
If Eli Lilly lowers pricing or insurance coverage improves to the point where Zepbound costs less than compounded, it would be a reasonable switch. LYV exists to make effective treatments accessible at fair prices. We are not in competition with Eli Lilly -- we are filling a cost gap.
How quickly can I start through LYV?
Take the quiz, complete the medical consultation, and your prescription ships within days. Most patients receive their first shipment within a week of completing the consultation. No insurance pre-authorization, no pharmacy back-and-forth.
See how LYV matches your goals
Take a 2-minute quiz. Get a personalized protocol.